NCT02384174

Brief Summary

The development of preventative nutritional strategies to promote healthy ageing is becoming increasingly important. Elevated thresholds for taste and smell, coupled with swallowing difficulties and masticatory dysfunction, often result in nutritionally imbalanced diets among the elderly. This can induce great changes in the composition and metabolic activities of the gut microbiome, leading to decreased intestinal motility and impaired bowel function. This can result in constipation or diarrhoea, increased basal levels of inflammation, immunosenescence and morbidity. The objectives of this study are to use dietary modification to improve gut health in older people. Diets high in resistant starch or dietary fibre will be given to 50 elderly volunteers (70-95 years) living in the community, in a randomised double-blind cross-over study. The aim is to investigate the effects on microbiome composition and functionality through fermentation, reduced putrefaction, and modification of blood markers associated with obesity and diabetes.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2015

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2015

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 10, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

July 27, 2020

Status Verified

July 1, 2020

Enrollment Period

1.7 years

First QC Date

February 20, 2015

Last Update Submit

July 24, 2020

Conditions

Keywords

AgingResistant starchDietary fibreImmune systemBacteriaolder subjects

Outcome Measures

Primary Outcomes (1)

  • Number of participants with change in levels of faecal bifidobacteria measured by quantitative fluorescent in situ hybridisation (FISH).

    4 weeks

Secondary Outcomes (4)

  • Number of participants with change in the bacterial composition of the faecal microbiome measured by quantitative FISH.

    4 weeks

  • Number of participants with change in inflammatory markers linked to ageing measured in whole blood by enzyme linked immunosorbent assay (ELISA).

    4 weeks

  • Number of participants with change in faecal genotoxic potential determined by measurement of faecal bacterial enzymes involved in the formation of genotoxic metabolites in the gut.

    4 weeks

  • Number of participants with a change in bowel habit and quality of life measured by completion of a bowel habit diary and quality of life questionnaire.

    4 weeks

Study Arms (2)

Resistant starch (RS)

EXPERIMENTAL

Resistant starch (RS3)

Dietary Supplement: Resistant starch

Dietary fibre

EXPERIMENTAL

Dietary fibre (Arabinogalactan, gum guar, pectin)

Dietary Supplement: Dietary fibre (arabinogalactan, gum guar, pectin)

Interventions

Resistant starchDIETARY_SUPPLEMENT
Resistant starch (RS)

Eligibility Criteria

Age70 Years - 95 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Men and women aged 70-95 years, with BMI 18.5-30.0 kg m2.

You may not qualify if:

  • Any autoimmune disease
  • Self-reported symptoms of acute or recent infection (including use of antibiotics within the previous 3 months)
  • Taking probiotics or prebiotics, including lactulose for constipation
  • Chronic gastrointestinal problems (e.g. Inflammatory Bowel Disease, Irritable Bowel Syndrome, cancer).
  • Specifically, volunteers who are diabetic will not be excluded from the investigation.
  • Assessment will be on a case by case basis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Cardiovascular and Diabetes Medicine/Gastroenterology, Ninewells Hospital and Medical School

Dundee, Tayside, DD1 9SY, United Kingdom

Location

Related Publications (3)

  • Woodmansey EJ, McMurdo ME, Macfarlane GT, Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol. 2004 Oct;70(10):6113-22. doi: 10.1128/AEM.70.10.6113-6122.2004.

    PMID: 15466557BACKGROUND
  • Bartosch S, Fite A, Macfarlane GT, McMurdo ME. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol. 2004 Jun;70(6):3575-81. doi: 10.1128/AEM.70.6.3575-3581.2004.

    PMID: 15184159BACKGROUND
  • Macfarlane S, Cleary S, Bahrami B, Reynolds N, Macfarlane GT. Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study. Aliment Pharmacol Ther. 2013 Oct;38(7):804-16. doi: 10.1111/apt.12453. Epub 2013 Aug 20.

    PMID: 23957631BACKGROUND

MeSH Terms

Interventions

Resistant StarchDietary Fiberarabinogalactanguar gumPectins

Intervention Hierarchy (Ancestors)

StarchGlucansBiopolymersPolymersMacromolecular SubstancesDietary CarbohydratesCarbohydratesPolysaccharidesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesPlant ExtractsPlant PreparationsBiological ProductsComplex Mixtures
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2015

First Posted

March 10, 2015

Study Start

May 1, 2015

Primary Completion

January 1, 2017

Study Completion

February 1, 2017

Last Updated

July 27, 2020

Record last verified: 2020-07

Locations